About Tianjin Lisheng Pharmaceutical Company

The company (stock code 002393) was founded in 1951 and is a pharmaceutical company that has grown along with the pace of industrial revitalization in New China. Over the past few decades, the company has produced high-quality pharmaceuticals to serve human health, received widespread praise from the community, and made positive contributions to China's medical and health industry. The company focuses on drug research and development, production and sales in the field of treatment of old and chronic diseases. The products cover 244 specifications in 15 categories, including cardiovascular system, digestive system, and antibiotics. The product dosage forms include tablets, capsules, granules, drops, solutions, injections, freeze-dried powder injections, etc. The main products are products such as Subisan indapamide tablets, Sanfish pain tablets, Siffonil cefdinil dispersible tablets, friendly flaxseed softgels, zinavirachin calcium injections, biohydrogenated sodium cinosuccinate lyophilized powder needles, sodium bicarbonate tablets, and a series of vitamin tablets. Honors received by the company: Model Tianjin's Most Socially Responsible Enterprise, China's Listed Company Golden Bull Award, 2017 Excellent Antihypertensive Product Brand in China's Pharmaceutical Industry, etc.